Cited by 54Ovarian function and disordersSexual Differentiation and DisordersDiabetes, Cardiovascular Risks, and Lipoproteins

Anti-Müllerian hormone in obese adolescent girls with polycystic ovary syndrome

Open access
Kim, Joon Young, Tfayli, Hala, Michaliszyn, Sara F., Lee, SoJung, Nasr, Alexis, Arslanian, Silva·2017·Journal of Adolescent Health

Abstract

Purpose Anti-Müllerian hormone (AMH) is proposed as a biomarker of polycystic ovary syndrome (PCOS). This study investigated: (1) AMH concentrations in obese adolescents with PCOS versus without PCOS; (2) the relationship of AMH to sex steroid hormones, adiposity, and insulin resistance; and (3) the optimal AMH value and the multivariable prediction model to determine PCOS in obese adolescents.Methods AMH levels were measured in 46 obese PCOS girls and 43 obese non-PCOS girls. Sex steroid hormones, clamp-measured insulin sensitivity and secretion, body composition, and abdominal adiposity were evaluated. Logistic regression and receiver-operating characteristic curve analyses were used, and multivariate prediction models were developed to test the utility of AMH for the diagnosis of PCOS.Results AMH levels were higher in obese PCOS versus non-PCOS girls (8.3 ± .6 vs. 4.3 ± .4 ng/mL, p < .0001), of comparable age and puberty. AMH concentrations correlated positively with age in both groups, total and free testosterone in PCOS girls only, abdominal adipose tissue in non-PCOS girls, with no correlation to in vivo insulin sensitivity and secretion in either groups. A multivariate model including AMH (cutoff 6.26 ng/mL, area under the curve .788) together with sex hormone-binding globulin and total testosterone exhibited 93.4% predictive power for diagnosing PCOS.Conclusions AMH may be a useful biomarker for the diagnosis of PCOS in obese adolescent girls.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jadohealth.2016.10.015

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kim, J. Y., Tfayli, H., Michaliszyn, S. F., Lee, S., Nasr, A., & Arslanian, S.
Affiliations
  • Children's Hospital of Pittsburgh (US)
  • American University of Beirut Medical Center (LB)
  • Youngstown State University (US)
Corresponding author
Arslanian, Silva
Venue
Journal of Adolescent Health
Publisher
Elsevier BV
Published
2017-03
Volume
60
Issue
3
Pages
333-339
ISSN
1054-139X (ISSN-L)
OpenAlex
W2565780667
Cited by
54
References
41
Citations by year
2026: 3 · 2025: 5 · 2024: 9 · 2023: 5 · 2022: 8 · 2021: 9 · 2020: 4 · 2019: 7 · 2018: 1 · 2017: 3
FWCI
4.88
Type
journal article
Language
en
Open access
Locations
  • Journal of Adolescent Health (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Rural and Environment Science and Analytical Services Division
  • National Institutes of Health (UL1TR000005)
  • National Institute of Child Health and Human Development
  • NIH Clinical Center
  • National Center for Advancing Translational Sciences
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD027503, K24HD001357)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
anti-Müllerian hormone, polycystic ovary syndrome, adolescent obesity, diagnostic biomarkers, sex hormones, insulin resistance, abdominal fat, sex hormone-binding globulin, total testosterone
MeSH terms
Adolescent, Cross-Sectional Studies, Female, Humans, Polycystic Ovary Syndrome, Biomarkers, Anti-Mullerian Hormone, Pediatric Obesity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review